Fig. 3

Specificity of UPT-POCT. a Specificity of UPT-POCT for antibodies against other coronaviruses, blood components, autoimmune diseases related antibodies, etc. PC, Positive Control, namely, a convalescent serum with 50-fold dilution; NC, Negative control, health people serum; RF: rheumatoid factor; ANA: antinuclear antibody; AMA: anti-mitochondrial antibody; SLE: systemic lupus erythematosus; HAMA: human anti-mouse antibody. b Specificity of UPT-POCT for antibodies against other viruses, including A/H1N1(2009), A/H1N1(2009) influenza virus; A/H1N1(or H3N2, H5N1, H7N9), A/H1N1 (or H3N2, H5N1, H7N9) influenza virus; B/Yamagata (or B/Victoria), B/Yamagata (or B/Victoria) influenza virus; RSV, respiratory syncytial virus; HRV-A (or -B, −C), human rhinovirus species A (or B, C); HAdV-1(or − 2, − 3, − 4, − 5, − 6, − 55), human adenovirus type 1(or 2, 3, 4, 5, 6, 55); CV-A16 (or -A24), coxsackievirus 16 (or 24); EV-A71 (or -A68), human enterovirus 71 (or 68); HEV-B: human enterovirus B; EBV, epstein-barr virus; MeV, measles virus; HCMV, human cytomegalovirus; RV, rotavirus; MuV, mumps virus; VZV, varicella-zoster virus; MP, mycoplasma pneumoniae; HNoV, Human norovirus. The number above each column is the number of samples. Each sample was tested three times, while the average value was exhibited if the number of samples was more than one